Cargando…

Downregulation of microRNA‐6125 promotes colorectal cancer growth through YTHDF2‐dependent recognition of N6‐methyladenosine‐modified GSK3β

BACKGROUND: MicroRNAs (miRNAs), the key regulator of gene expression, and N6‐methyladenosine (m6A) RNA modification play a significant role in tumour progression. However, regulation of m6A‐modified mRNAs by miRNAs in colorectal cancer (CRC), and its effect on progression of CRC, remains to be inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongyan, Zhang, Ning, Jiao, Xueli, Wang, Cong, Sun, Wenhao, He, Yanyu, Ren, Ganglin, Huang, Shirui, Li, Mengjie, Chang, Yixin, Jin, Zihui, Xie, Qipeng, Zhang, Xiaodong, Huang, Haishan, Jin, Honglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516342/ https://www.ncbi.nlm.nih.gov/pubmed/34709763 http://dx.doi.org/10.1002/ctm2.602

Ejemplares similares

uc.77- Downregulation Promotes Colorectal Cancer Cell Proliferation by Inhibiting FBXW8-Mediated CDK4 Protein Degradation
por: Zheng, Zhijian, et al.
Publicado: (2021)

LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter
por: Ren, Ganglin, et al.
Publicado: (2023)

Coiled-Coil Domain-Containing 68 Downregulation Promotes Colorectal Cancer Cell Growth by Inhibiting ITCH-Mediated CDK4 Degradation
por: Wang, Cong, et al.
Publicado: (2021)

Downregulation of N(6)-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N(6)-methyladenosine levels
por: Li, Jiangfeng, et al.
Publicado: (2017)

N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
por: Chen, Lin, et al.
Publicado: (2023)

N6‐methyladenosine reader YTHDF3 regulates melanoma metastasis via its ‘executor'LOXL3
por: Shi, Hao‐ze, et al.
Publicado: (2022)

O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner
por: Yang, Yang, et al.
Publicado: (2023)

N(6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
por: Xia, Tian‐Liang, et al.
Publicado: (2021)

Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N(6)-Methyladenosine-Modified RNAs
por: Micaelli, Mariachiara, et al.
Publicado: (2022)

RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68
por: Nie, Qihong, et al.
Publicado: (2023)

The N(6)-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response
por: Zong, Xin, et al.
Publicado: (2021)

CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression
por: Jin, Zihui, et al.
Publicado: (2023)

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
por: Quintanilha, Julia C. F., et al.
Publicado: (2021)

FBW7 suppresses ovarian cancer development by targeting the N(6)-methyladenosine binding protein YTHDF2
por: Xu, Fei, et al.
Publicado: (2021)

Plant YTHDF proteins are direct effectors of antiviral immunity against an N6 ‐methyladenosine‐containing RNA virus
por: Martínez‐Pérez, Mireya, et al.
Publicado: (2023)

N(6)-Methyladenosine RNA-Binding Protein YTHDF1 in Gastrointestinal Cancers: Function, Molecular Mechanism and Clinical Implication
por: Chen, Danyu, et al.
Publicado: (2022)

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Su, Ganglin, et al.
Publicado: (2021)

Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis
por: Lou, Zhefeng, et al.
Publicado: (2021)

MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer
por: Jin, Honglei, et al.
Publicado: (2018)

N(6)-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
por: Wang, Qianqing, et al.
Publicado: (2020)

The N6-Methyladenosine (m6A) Methylation Gene YTHDF1 Reveals a Potential Diagnostic Role for Gastric Cancer
por: Liu, Tong, et al.
Publicado: (2020)

Ythdf is a N6‐methyladenosine reader that modulates Fmr1 target mRNA selection and restricts axonal growth in Drosophila
por: Worpenberg, Lina, et al.
Publicado: (2021)

RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m(6)A-YTHDF2-dependent manner
por: Tan, Zhen, et al.
Publicado: (2022)

YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
por: Li, Jiangfeng, et al.
Publicado: (2020)

METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding
por: Wang, Wei, et al.
Publicado: (2021)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through YTHDF3 Modulating Macrophage Polarization
por: Wu, Yihao, et al.
Publicado: (2022)

p85α promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation
por: Xie, Qipeng, et al.
Publicado: (2016)

Methyltransferase-Like 3 Rescues the Amyloid-beta protein-Induced Reduction of Activity-Regulated Cytoskeleton Associated Protein Expression via YTHDF1-Dependent N6-Methyladenosine Modification
por: Xu, Chenhaoyi, et al.
Publicado: (2022)

METTL3 Regulated the Meat Quality of Rex Rabbits by Controlling PCK2 Expression via a YTHDF2–N6-Methyladenosine Axis
por: Luo, Gang, et al.
Publicado: (2022)

N6-methyladenosine methylation-related genes YTHDF2, METTL3, and ZC3H13 predict the prognosis of hepatocellular carcinoma patients
por: Wang, Yun, et al.
Publicado: (2022)

ISO, via Upregulating MiR-137 Transcription, Inhibits GSK3β-HSP70-MMP-2 Axis, Resulting in Attenuating Urothelial Cancer Invasion
por: Guo, Xirui, et al.
Publicado: (2018)

Author Correction: METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding
por: Wang, Wei, et al.
Publicado: (2021)

H19 recruited N(6)-methyladenosine (m(6)A) reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer
por: Bai, Rumeng, et al.
Publicado: (2023)

Cytoplasmic m(1)A reader YTHDF3 inhibits trophoblast invasion by downregulation of m(1)A-methylated IGF1R
por: Zheng, Qingliang, et al.
Publicado: (2020)

N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation
por: Xu, Jing, et al.
Publicado: (2022)

N(6)-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m(6)A/cyclin D1 in asthma
por: Wang, Juan, et al.
Publicado: (2023)

YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation
por: Li, Jiong, et al.
Publicado: (2021)

YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m(6)A
por: Hong, Ling, et al.
Publicado: (2021)

GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells
por: Xu, Hao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kbpoovuc02su4pp3u8ji0s97rj